| At a glance | Most common sustained arrhythmia: irregularly irregular rhythm with no discrete P waves. | Macro-reentrant atrial tachycardia with sawtooth flutter waves; treated like AFib for stroke risk. |
|---|
| Classic presentation | Palpitations (most common); Dyspnea, fatigue, exercise intolerance; Lightheadedness, presyncope; rarely syncope; Often asymptomatic — found incidentally on exam or wearable device; Acute presentation may be embolic stroke or decompensated HF; Irregularly irregular pulse — hallmark exam finding; confirm with ECG (MAT, frequent PACs, and… | ECG: 'sawtooth' flutter waves (negative deflections in II, III, aVF and positive in V1) in typical counterclockwise flutter.; Often more symptomatic than AFib due to faster, regular ventricular rates; Palpitations, dyspnea, exercise intolerance; Lightheadedness, chest discomfort; May present as new HF or with embolic stroke; Regular… |
|---|
| Workup / key labs | TSH (thyrotoxicosis), CBC, BMP, magnesium; Troponin if ischemia suspected; Coagulation studies prior to anticoagulation | TSH, CBC, BMP, magnesium; Coagulation studies; Troponin if ischemia in differential |
|---|
| Imaging | 12-lead ECG: irregularly irregular RR, no P waves, narrow QRS (unless aberrancy/pre-existing BBB); Holter or event monitor for paroxysmal AFib not captured on ECG; TTE: LA size, LV function, valve disease, LVH; TEE prior to cardioversion if >48 h duration or unknown onset and not therapeutically anticoagulated for ≥3 weeks | 12-lead ECG — diagnostic when flutter waves visible; 2:1 conduction can hide them (rate 150 should prompt vagal maneuvers or adenosine to unmask); TTE for LA size, LV function, valve disease; TEE prior to cardioversion if duration unknown/>48 h and not adequately anticoagulated |
|---|
| First-line treatment | Hemodynamically unstable (hypotension, shock, pulmonary edema, ischemia) → immediate synchronized electrical cardioversion. If stable, acute rate control (HR <110 at rest is reasonable target; <80 for symptomatic):; • Beta-blocker (metoprolol, esmolol IV) — first-line; • Non-dihydropyridine CCB (diltiazem, verapamil) — avoid if HFrEF; •… | Hemodynamically unstable (hypotension, altered mental status, shock, pulmonary edema, ischemia) → immediate synchronized cardioversion. If stable, acute rate control: same as AFib — IV beta-blocker or non-DHP CCB; Anticoagulation: same CHA2DS2-VASc-based decision as AFib (flutter carries equivalent stroke risk). Before elective… |
|---|